Metropolis Healthcare Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 5 Aug 2026

Company page: Metropolis Healthcare share price, financials & guidance record

Metropolis Healthcare reported a strong Q1 FY27, with revenue growing 17% year-on-year to INR 450 crores, driven by robust volume growth across B2C and B2B segments. Profitability significantly improved, with EBITDA margin expanding 210 basis points to 25.2%. The company reiterated its full-year revenue growth guidance of 14-15% and aims for an EBITDA margin of 27-28% through operational efficiencies and network expansion.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue down 26.1%, net profit up 26.7% against the same quarter last year.

₹ Cr · quarterly

Line item	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	11	4	23	23	26 +136%	23 +475%	17 −26%
Expenses	251	283	296	321	311	317	339
EBITDA	72	62	90	108	95 +32%	108 +74%	111 +23%
Margin	22%	18%	23%	25%	23%	25%	25%
Other income	3	7	8	1	0	8	5
Interest	5	5	5	6	6	8	6
Depreciation	28	29	31	32	32	39	32
Profit before tax	42	36	61	71	57 +36%	70 +94%	78 +28%
Tax rate	26%	19%	26%	26%	26%	27%	27%
Net profit	31	29	45	53	42 +35%	51 +76%	57 +27%
EPS	1.53	1.41	2.17	2.54	2.00	2.46	2.73

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls